TAVI in patients younger than 65 years: when evidence has not yet reached the age of the patients
A new U.S. study analyzes outcomes of transcatheter aortic valve implantation (TAVI) versus conventional surgical aortic valve replacement (SAVR) in patients younger than 65 years, highlighting the growing expansion of TAVI despite limited evidence on long-term durability.
